HCW Biologics Inc. Common Stock (HCWB) is a publicly traded Healthcare sector company. As of May 21, 2026, HCWB trades at $2.06 with a market cap of $9.02M and a P/E ratio of -0.38. HCWB moved +133.49% today. Year to date, HCWB is +118.92%; over the trailing twelve months it is -73.53%. Its 52-week range spans $0.25 to $100.80. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces HCWB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HCW Biologics Inc. Common Stock (HCWB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HCWB moved +133.49% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.06 |
| Market Cap | $9.02M |
| P/E Ratio | -0.38 |
| EPS | $-7.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $100.80 |
| 52-Week Low | $0.25 |
| Volume | 853.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.55M |
| Net Income | $-2.29M |
| Gross Margin | 99.89% |
1 analysts cover HCWB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.